SCHEMBL31154563

SCHEMBL31154563

COc1cc(C2SCCS2)ccc1OC(=O)C=Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 2/20 0.48
HTR1A P08908 1/20 0.47
KDM4E B2RXH2 3/20 0.46
LMNA P02545 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MMP1 P03956 1/20 0.45
TSHR P16473 2/20 0.45
KMT2A Q03164 4/20 0.44
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
RAB9A P51151 2/20 0.43
JUN P05412 1/20 0.43
NFKB1 P19838 1/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TTR P02766 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25412469 0.96 TSHR (0.47) TNFRSF1AHTR1AKDM4ELMNAALDH1A1
SCHEMBL25412467 0.96 TSHR (0.47) TNFRSF1AHTR1AKDM4ELMNAALDH1A1
SCHEMBL25411775 0.85 TSHR (0.46) KDM4EALDH1A1MMP1TSHRKMT2A
SCHEMBL29793393 0.82 ESR1 (0.42) HTR1ALMNAALDH1A1HPGDNPSR1
SCHEMBL24686372 0.81 LMNA (0.42) HTR1ALMNAALDH1A1NPSR1MMP1
SCHEMBL29793383 0.81 LMNA (0.43) HTR1ALMNAALDH1A1HPGDNPSR1
SCHEMBL31154557 0.80 KMT2A (0.58) HTR1AKDM4ELMNAALDH1A1KMT2A
SCHEMBL17301255 0.79 HTR1A (0.60) TNFRSF1AHTR1AKDM4EALDH1A1MMP1
SCHEMBL25410639 0.79 KMT2A (0.48) TNFRSF1AHTR1AKDM4ELMNAALDH1A1
SCHEMBL25410633 0.79 KMT2A (0.48) TNFRSF1AHTR1AKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300883-A1 STYRYL CARBOXYLATE DERIVATIVES Renovel Innovations, Inc. 2024-09-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300883-A1 STYRYL CARBOXYLATE DERIVATIVES SCD, ACACB, ACACA TNFRSF1A 981/4885HTR1A 3716/4885KDM4E 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.